Breast cancer imaging with radiolabeled antibodies

Seminars in Nuclear Medicine

Volumn 29, Issue 1, 1999, Pages 41-48

  Goldenberg, D M ^a   Nabi, H A ^a  

^a GARDEN STATE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MUCIN;

BREAST CANCER; CANCER SCREENING; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOIMMUNOASSAY; REVIEW;

EID: 0032890674     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(99)80028-2     Document Type: Article

References (72)

1. Landis SH Murray T Bolden S Wingo PA Cancer statistics, 1998 CA Cancer J Clin 48 1998 6 29
2. Goldenberg DM DeLand F Kim E Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning N Engl J Med 298 1978 1384 1388
3. Thor AD Edgerton SM Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications Semin Nucl Med 19 1989 295 308
4. Goldenberg DM Larson SM Radioimmunodetection in cancer identification J Nucl Med 33 1992 803 814
5. Baum RP Brümmendorf TH Radioimmunolocalization of primary and metastatic breast cancer Quart J Nucl Med 42 1998 33 42
6. Nabi HA Antibody imaging in breast cancer Sem Nucl Med 27 1997 30 39
7. Goldenberg DM Kim EE DeLand FH Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen Cancer Res 40 1980 2984 2992
8. DeLand F Kim E Corgan R Axillary lymphoscintigraphy in radioimmunodetection of carcinoembryonic antigen in breast cancer J Nucl Med 20 1979 1243 1250
9. 2 fragments of an anticarcinoembryonic antigen monoclonal antibody: a multicenter study Cancer Res 49 1989 3095 3103
10. Lind P Smola MG Lechner P The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer Int J Cancer 47 1991 865 869
11. Rosner D Nabi H Wild L Ortman-Nabi J Hreshchyshyn MM Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG) Cancer Invest 13 1995 573 582
12. Shousha S Lyssiotis T Godfrey VM Scheuer PJ Carcinoembryonic antigen in breast cancer tissue: a useful prognostic indicator Br Med J 1 1979 777 779
13. Esteban JM Felder B Ahn C Simpson JF Battifora H Shively JE Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients Cancer 74 1994 1575 1583
14. Schmitt FC Andrade L Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer J Clin Pathol 48 1995 53 56
15. Chung JK Jang JJ Lee DS Lee MC Koh CS Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography J Nucl Med 35 1994 1499 1505
16. + cell selection Blood 90 1997 3546
17. Robertson JFR Ellis IO Bell J Carcinoembryonic antigen immunocytochemistry in primary breast cancer Cancer 64 1989 1638 1645
18. Colcher D Hand P Nuti M Schlom J A spectrum of monoclonal antibodies reactive with human mammary tumor cells Proc Natl Acad Sci USA 78 1981 3199 3203
19. Colcher D Zalutsky M Kaplan W Kufe D Austin F Schlom J Radiolocalization of human mammary tmors in athymic mice by a monoclonal antibody Cancer Res 43 1983 736 742
20. Hayes DF Zalutsky MR Kaplan W Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer Cancer Res 46 1986 3157 3163
21. Schlom J Greiner J Horan-Hand P Human breast cancer markers defined by monoclonal antibodies Sell S Reisfeld R Monoclonal Antibodies in Cancer 1985 Humana Press Inc Clifton, NJ 247 277
22. Dillman RO Beauregard JC Sobol RE Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody crossreactivity with an antigen on circulating cells Cancer Res 44 1984 2213 2218
23. Price MR Rye PD Petrakou E Summary report on the ISOBM TD-4 workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin Tumour Biol 19 1998 1 20
24. Karsten U Diotel C Klich G Paulsen H Goletz S Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation Cancer Res 58 1998 2541 2549
25. 2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients Int J Cancer 9 1988 89 95
26. 99mTc SM3 radioimmunoscintigraphy Acta Oncol 35 1996 319 321
27. Hayes DF Noska MA Kufe DW Zalutsky MR Effect of radioiodination on the binding of monoclonal antibody DF3 to breast carcinoma cells Nucl Med Biol 15 1988 235 241
28. Brümmendorf TH Kaul S Baum RP Immunoscintigraphic imaging of breast cancer with 99m-Tc labeled antimucin antibody 12H12: experimental and first clinical results Tumor Targeting 2 1996 29 36
29. Brümmendorf TH Kaul S Schuhmacher J Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM2 labeled with 99m-Tc and radioiodine Cancer Res 54 1994 4162 4168
30. 99mTc Nucl Med 34 1995 197 202
31. 2 fragments Nucl Med Biol 20 1991 325 335
32. 111In labeled monoclonal antibody (MA5) against a mucin-like antigen Cancer Res 50 1990 927 931
33. Lamki LM Buzdar AU Singletary E Rosenblum MG Bhadkamkar V Esparza L Indium-111 labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study J Nucl Med 32 1991 1326 1332
34. Crippa F Agresti R Bombardieri E Preliminary results of pre-axillary radioimmunoscintigraphy with In-111 B7w.3 in breast cancer Int J Oncol 6 1995 791 795
35. Mattes MJ Major PP Goldenberg DM Pattern of antigen distribution in human carcinomas Cancer Res 50 1990 880 884
36. [Abstract] McEwan A MacLean GD Goldberg L Evaluating radioimmunoscintigraphy in patients with breast cancer Eur J Nucl Med 21 1994 748|P
37. Sledge GW Jr Implications of the new biology for therapy in breast cancer Semin Oncol 23 1996 76 81
38. Divgi CR Welt C Kris M Phase I and imaging trial of Indium-111 labeled anti-EGF receptor monoclonal antibody 225 in patients with squamous cell carcinoma J Natl Cancer Inst 23 1991 97 104
39. Pauletti G Godolphin W Press MF Slamon DJ Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization Oncogene 12 1996 63 72
40. Allan SM Dean CJ Eccles S Sacks NP Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2 Cell Biophys 24–25 1994 93 98
41. Begent RH Verhaar MJ Chester KA Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library Nature Med 2 1996 979 984
42. 99mTc-labeling kit for antibody imaging Cancer Res 50 1990 794s 798s
43. Khalkhali I Cutrone JA Mena IG Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma Radiology 196 1995 421 426
44. Khalkhali I Cutrone J Mena I Technetium-99m-sestamibi sintimammography of breast lesions: clinical and pathological follow-up J Nucl Med 36 1995 1784 1789
45. Waxman AD The role of 99mTc methoxyisobutylisonitrile in imaging breast cancer Sem Nucl Med 27 1997 40 54
46. Palmedo HJ Lastoria S Maublant J Scintimmography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial Eur J Nucl Med 25 1998 375 385
47. [Abstract] Nabi HA Goldenberg DM Lamki L The role of carcinoembryonic antigen (CEA) imaging in the diagnosis of breast carcinoma Eur J Nucl Med 25 1998 872
48. [Abstract] Rosner D Abdel-Nabi H Panaro V Immunoscintigraphy (IS) may reduce the number of surgical biopsies in women with benign breast disease (BBD) and indeterminate mannograms Tumor Targeting 2 1996 143 144
49. Tolmos J Cutrone JA Wang B Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography J Natl Cancer Inst 90 1998 846 849
50. Paganelli G De Cicco C Cremonesi M Optimized sentinel node scintigraphy in breast cancer Quart J Nucl Med 42 1998 49 53
51. Krag D Weaver D Ashikaga T The sentinel node in breast cancer—a multicenter validation study N Engl J Med 339 1998 941 946
52. Bombardieri E Crippa F Maffioli L Nuclear medicine approaches for detection of axillary lymph node metastases Quart J Nucl Med 42 1998 54 65
53. DeJager R Abdel-Nabi H Serafini A Status of cancer immunodetection with radiolabeled human monoclonal antibodies Semin Nucl Med 23 1993 165 179
54. Kramer EL DeNardo SJ Liebes L Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody Adv Exp Med Biol 353 1994 181 192
55. Kramer EL Liebes L Wasserheit C Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer Clin Cancer Res 4 1998 1679 1688
56. 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial Cancer Res 55 1995 5921s 5924s
57. Ozzello L De Rosa CM Blank EW The use of natural interferon alpha conjugated to a monoclonal antibody antimammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts Breast Cancer Res Treat 25 1993 265 276
58. Ozzello L Blank EW De Rosa CM Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts Breast Cancer Res Treat 48 1998 135 147
59. Murray JL Macey DJ Grant EJ Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Res 55 1995 5925s 5928s
60. Guadagni F Schlom J Pothen S Pestka S Greiner JW Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon Cancer Immunol Immunother 26 1988 222 230
61. Buckman R De Angelis C Shaw P Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3 Gynecol Oncol 47 1992 102 109
62. (Suppl) DeNardo SJ Mirick GR Kroger The biologic window for chimeric L6 radioimmunotherapy Cancer 73 1994 1023 1032
63. DeNardo SJ O'Grady LF Richman CM Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody Anticancer Res 17 1997 1745 1751
64. DeNardo SJ Kukis DL Kroger LA Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts Proc Natl Acad Sci USA 94 1997 4000 4004
65. Shih LB Xuan H Aninipot R Stein R Goldenberg DM In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer Cancer Res 55 1995 5857s 5863s
66. Pegram MD Lipton A Hayes DF Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 1998 2659 2671
67. De Santes K Slamon D Anderson SK Radiolabeled antibody targeting of the HER-2/neu oncoprotein Cancer Res 52 1992 1916 1923
68. Dean CJ Eccles SA Valeri M Rat Mabs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer Cell Biophys 22 1993 111 127
69. Jinno H Ueda M Enomoto K Ikeda T Kitajima M Targeting therapy using monoclonal antibody directed against growth factor receptors Hum Cell 6 1993 188 193
70. Merino MJ Monteagudo C Neumann RD Monoclonal antibodies for radioimmunoscintigraphy of breast cancer Int J Rad Appl Instrum 18 1991 437 443
71. ®) with the positron-emitting radionuclide, Tc-94m Cancer Biother Radiopharm 13 4 1998 318
72. Goldenberg DM Current status of cancer imaging with radiolabeled antibodies J Cancer Res Clin Oncol 113 1987 203 208